1/541
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Serum, usually from a red-top tube.
Plasma.
Heparin, often collected on ice.
Sodium fluoride, gray-top tube.
Enolase, an enzyme in glycolysis.
It inhibits enolase and slows glycolysis, preventing glucose from being consumed by cells.
Acid phosphatase decreases pH.
EDTA contains Na+ or K+ and can falsely increase those results.
EDTA chelates calcium, making the calcium result falsely low.
RBC rupture that releases intracellular contents into serum or plasma.
Potassium.
Lactate dehydrogenase.
Aldolase.
Acid phosphatase.
Magnesium.
Phosphate.
An extra band from released hemoglobin.
It can increase iron.
It can decrease or increase bilirubin depending on hemoglobin and bilirubin concentration.
Glucose.
Hormonal regulation.
Glucose is the preferred energy source for life processes.
About 10 mg/dL per hour due to cellular glycolysis.
Glucose remains stable longer because cell metabolism slows.
Sodium fluoride.
They are about 2 to 3 mg/dL higher than venous values.
CSF glucose is about 60 to 65 percent of plasma glucose.
Insulin.
Beta cells of the islets of Langerhans in the pancreas.
It decreases serum glucose by stimulating cellular glucose uptake.
Glucagon.
It increases serum glucose by stimulating glycogenolysis, the breakdown of glycogen to glucose.
ACTH.
Growth hormone.
Cortisol.
It stimulates gluconeogenesis, the production of glucose from non-carbohydrate sources.
Human placental lactogen.
Epinephrine.
It stimulates glycogenolysis and sympathetic activity.
T3 and T4.
They increase serum glucose by stimulating glycogenolysis.
Glucagon, ACTH, growth hormone, cortisol, human placental lactogen, epinephrine, T3, and T4.
Decreased insulin production or ineffective insulin action.
Polyuria.
Polydipsia.
Polyphagia.
Poor wound healing.
Weight loss.
Glucose.
Urine glucose.
A1c.
Cholesterol.
Increased H+ due to metabolic acidosis.
Ketones in blood and urine.
Less than 100 mg/dL.
Greater than or equal to 126 mg/dL.
100 to less than 126 mg/dL.
Less than 140 mg/dL.
Greater than or equal to 200 mg/dL.
140 to less than 200 mg/dL.
Greater than or equal to 200 mg/dL with unexplained weight loss, polyuria, or polydipsia.
Less than 5.6 percent.
Greater than or equal to 6.5 percent.
5.7 to 6.4 percent.
75 g glucose.
1.75 g per kg, up to a maximum of 75 g.
100 g glucose.
Fasting, 1 hour, 2 hours, and 3 hours.
Greater than 95 mg/dL.
Greater than 180 mg/dL.
Greater than 155 mg/dL.
Greater than 140 mg/dL.
Hemoglobin with glucose attached to it, used to estimate average glucose control.
About 90 days.
A percent and it can be converted to estimated average glucose.
An abnormal hemoglobin pattern.
Glucose attached to serum proteins, including albumin.
About 2 to 3 weeks.
Microalbuminuria testing.
Small amounts of albumin in urine to assess early renal damage.
A peptide cleaved from proinsulin when insulin is produced.
Endogenous insulin production.
It helps show how much insulin the patient is producing naturally.
eAG = 28.7 x A1c
Estimated average glucose.
About 126 mg/dL.
About 28 mg/dL.
A higher glucose peak with delayed return toward baseline.
An enzymatic glucose method.
Glucose oxidase.
Peroxidase.
It can decrease pO2 and affect oxygen-dependent reactions.
It is designed for urine screening and uses a color-strip reaction.
An enzymatic reference-type method using hexokinase and NAD/NADP chemistry.
Glucose + ATP forms glucose-6-phosphate + ADP.
340 nm.
Lactase deficiency in the small bowel.
A mean glucose rise less than 20 mg/dL.
Vomiting, diarrhea, or intestinal discomfort.
To evaluate intestinal absorption without needing pancreatic enzymes.